Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sharmilan Thanendrarajan

Concepts (239)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
60
2025
2998
4.150
Why?
Antibodies, Bispecific
6
2025
88
1.190
Why?
Hematopoietic Stem Cell Transplantation
9
2024
578
1.100
Why?
Leukemia, Plasma Cell
2
2020
32
0.860
Why?
Immunotherapy, Adoptive
5
2024
163
0.720
Why?
Bone Marrow
10
2022
363
0.690
Why?
B-Cell Maturation Antigen
7
2025
99
0.690
Why?
Neoplasms, Plasma Cell
3
2024
36
0.640
Why?
Humans
69
2025
50503
0.600
Why?
Plasma Cells
6
2023
221
0.590
Why?
Chromosome Deletion
2
2023
134
0.580
Why?
Transplantation, Autologous
10
2024
481
0.560
Why?
Chromosomes, Human, Pair 17
1
2017
34
0.560
Why?
Gene Expression Profiling
10
2023
1025
0.540
Why?
Tumor Suppressor Protein p53
2
2017
213
0.520
Why?
Clinical Trials as Topic
4
2022
486
0.520
Why?
Gene Expression Regulation, Neoplastic
6
2021
833
0.510
Why?
Neoplasm, Residual
6
2022
160
0.490
Why?
Proteasome Inhibitors
1
2016
104
0.480
Why?
Immunologic Factors
1
2016
111
0.480
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
0.480
Why?
Aged
23
2025
9741
0.450
Why?
Prognosis
15
2024
1978
0.440
Why?
Immunotherapy
1
2016
235
0.440
Why?
Stem Cell Transplantation
5
2024
179
0.430
Why?
Translocation, Genetic
5
2021
240
0.430
Why?
Mutation
7
2022
1280
0.420
Why?
Antibodies, Monoclonal
2
2022
462
0.420
Why?
Neoplasm Proteins
4
2020
320
0.400
Why?
Neutropenia
2
2023
116
0.390
Why?
Survival Analysis
8
2024
661
0.380
Why?
Neoplasms
2
2012
1251
0.380
Why?
Cytokine-Induced Killer Cells
1
2011
2
0.380
Why?
Lymphocytes
1
2012
149
0.370
Why?
Evolution, Molecular
2
2021
95
0.350
Why?
Cancer Vaccines
1
2011
80
0.350
Why?
Neoplasm Recurrence, Local
7
2024
629
0.350
Why?
Positron-Emission Tomography
4
2022
292
0.340
Why?
Diffusion Magnetic Resonance Imaging
3
2019
125
0.330
Why?
Cytokines
1
2012
606
0.310
Why?
Tumor Microenvironment
3
2024
222
0.300
Why?
Female
27
2025
27081
0.300
Why?
Middle Aged
21
2025
12611
0.290
Why?
Aged, 80 and over
9
2025
3226
0.290
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
1000
0.290
Why?
Hematologic Neoplasms
2
2022
99
0.290
Why?
Combined Modality Therapy
4
2024
641
0.270
Why?
Atrial Fibrillation
2
2022
188
0.270
Why?
Male
25
2025
25907
0.250
Why?
Adult
17
2025
13577
0.240
Why?
Fluorodeoxyglucose F18
4
2021
189
0.240
Why?
Proto-Oncogene Proteins B-raf
3
2020
80
0.230
Why?
Immunoglobulins, Intravenous
1
2025
65
0.230
Why?
Polycomb Repressive Complex 2
2
2021
46
0.230
Why?
Neoplasms, Second Primary
1
2024
74
0.220
Why?
Treatment Outcome
8
2024
5283
0.220
Why?
Chromosomes, Human, Pair 1
2
2023
92
0.210
Why?
Disease Progression
6
2021
829
0.200
Why?
Risk Factors
9
2024
3724
0.200
Why?
Paraproteinemias
1
2022
72
0.200
Why?
Immunoconjugates
1
2022
38
0.190
Why?
Osteolysis
1
2022
74
0.190
Why?
Drug Approval
1
2022
47
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Lymphoma, B-Cell
1
2022
49
0.190
Why?
Recurrence
6
2024
659
0.190
Why?
Epigenomics
1
2021
68
0.190
Why?
Patient Participation
1
2022
70
0.190
Why?
T-Lymphocytes
4
2024
325
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Cell Cycle
1
2021
226
0.170
Why?
Practice Guidelines as Topic
1
2023
468
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Bone Resorption
1
2022
302
0.170
Why?
Bone Diseases
1
2021
96
0.170
Why?
Retrospective Studies
8
2025
6263
0.170
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Disease-Free Survival
5
2019
444
0.160
Why?
Antigens, CD
1
2020
222
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
281
0.160
Why?
Spleen
1
2019
169
0.150
Why?
Spinal Fractures
1
2018
38
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Antineoplastic Agents
2
2024
1172
0.150
Why?
Bacteremia
1
2019
89
0.150
Why?
Brain Neoplasms
2
2011
291
0.150
Why?
Adipocytes
1
2018
126
0.140
Why?
Gene Rearrangement
1
2018
65
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Retinoblastoma Binding Proteins
1
2017
11
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Epigenesis, Genetic
1
2020
372
0.140
Why?
Pelvis
1
2017
66
0.140
Why?
Cell Proliferation
4
2023
985
0.130
Why?
Lymphoma, Large B-Cell, Diffuse
2
2022
90
0.130
Why?
Survival Rate
4
2020
909
0.130
Why?
Immunoglobulin Light Chains
1
2017
84
0.130
Why?
Ubiquitin-Protein Ligases
1
2017
95
0.130
Why?
Clonal Evolution
1
2016
56
0.130
Why?
Flow Cytometry
1
2018
474
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.130
Why?
Gene Expression
1
2018
610
0.120
Why?
Animals
4
2024
13124
0.120
Why?
Cystatin M
2
2024
19
0.110
Why?
Cross-Sectional Studies
3
2023
1610
0.100
Why?
Cardiovascular Diseases
1
2017
461
0.100
Why?
Follow-Up Studies
3
2024
2242
0.090
Why?
Lymphoma, Non-Hodgkin
1
2011
55
0.090
Why?
Astrocytoma
1
2011
21
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
Disease Models, Animal
1
2016
1436
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
231
0.090
Why?
Glioma
1
2011
77
0.090
Why?
Alleles
2
2021
256
0.080
Why?
Genomics
2
2023
279
0.080
Why?
Remission Induction
2
2021
208
0.080
Why?
Tumor Burden
2
2020
130
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
67
0.080
Why?
Histones
2
2021
297
0.080
Why?
Vaccination
1
2011
280
0.080
Why?
Transcription Factors
2
2023
565
0.080
Why?
DNA Copy Number Variations
2
2021
109
0.080
Why?
Radiopharmaceuticals
2
2021
204
0.080
Why?
Models, Biological
1
2011
716
0.070
Why?
Cell Differentiation
2
2022
640
0.070
Why?
Transcriptome
2
2020
313
0.070
Why?
Kaplan-Meier Estimate
2
2019
464
0.070
Why?
Imaging, Three-Dimensional
2
2017
150
0.060
Why?
Biopsy
2
2018
588
0.060
Why?
Arkansas
2
2021
1985
0.060
Why?
Killer Cells, Natural
1
2024
106
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Demography
1
2024
94
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.060
Why?
X-Ray Microtomography
1
2024
79
0.060
Why?
CD8-Positive T-Lymphocytes
1
2024
125
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
49
0.050
Why?
Antibodies
1
2024
153
0.050
Why?
Mice
2
2024
5687
0.050
Why?
Signal Transduction
2
2021
1624
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
48
0.050
Why?
Geography
1
2022
60
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
United States Food and Drug Administration
1
2022
90
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Chromosome Aberrations
1
2023
280
0.050
Why?
Dexamethasone
1
2024
432
0.050
Why?
Phylogeny
1
2022
236
0.050
Why?
Bone Marrow Transplantation
1
2022
136
0.050
Why?
Syndecan-1
1
2021
75
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
RANK Ligand
1
2022
187
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
81
0.050
Why?
Transcriptional Activation
1
2021
119
0.050
Why?
Chromatin
1
2021
137
0.050
Why?
Clone Cells
1
2021
70
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
226
0.040
Why?
Pyrimidines
1
2022
191
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Genome, Human
1
2021
109
0.040
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
Why?
DNA, Neoplasm
1
2020
143
0.040
Why?
Health Status Disparities
1
2022
202
0.040
Why?
Genetic Variation
1
2020
207
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
Cell Line, Tumor
1
2023
1398
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
169
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Computational Biology
1
2020
215
0.040
Why?
Pseudomonas Infections
1
2019
48
0.040
Why?
Syndrome
1
2019
240
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
DNA-Binding Proteins
1
2021
418
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
Why?
Oncogene Proteins, Fusion
1
2018
57
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Protein-Tyrosine Kinases
1
2018
88
0.040
Why?
Kidney Function Tests
1
2017
51
0.040
Why?
STAT3 Transcription Factor
1
2017
77
0.040
Why?
Retinoblastoma Protein
1
2017
19
0.030
Why?
False Positive Reactions
1
2017
59
0.030
Why?
Fibroblast Growth Factors
1
2017
45
0.030
Why?
Bone and Bones
1
2021
478
0.030
Why?
Glomerular Filtration Rate
1
2017
119
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.030
Why?
Amino Acid Sequence
1
2018
574
0.030
Why?
Alkaline Phosphatase
1
2017
93
0.030
Why?
Sequence Analysis, DNA
1
2017
226
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
NF-kappa B
1
2018
315
0.030
Why?
Glycolysis
1
2016
69
0.030
Why?
DNA Methylation
1
2020
550
0.030
Why?
Models, Genetic
1
2016
172
0.030
Why?
Genomic Instability
1
2016
90
0.030
Why?
Staphylococcal Infections
1
2019
267
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
105
0.030
Why?
Logistic Models
1
2018
900
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Melphalan
1
2016
178
0.030
Why?
Heart
1
2017
341
0.030
Why?
Kidney Diseases
1
2017
213
0.030
Why?
Algorithms
1
2018
625
0.030
Why?
Echocardiography
1
2017
400
0.030
Why?
Time Factors
1
2021
2935
0.030
Why?
Myocardium
1
2017
445
0.030
Why?
Disease Management
1
2015
178
0.030
Why?
Thalidomide
1
2016
378
0.030
Why?
Longitudinal Studies
1
2016
735
0.030
Why?
Risk Assessment
1
2018
1270
0.030
Why?
Dose-Response Relationship, Drug
1
2016
1372
0.030
Why?
Ifosfamide
1
2011
11
0.020
Why?
Dacarbazine
1
2011
10
0.020
Why?
Carboplatin
1
2011
54
0.020
Why?
Tomography, X-Ray Computed
1
2017
1164
0.020
Why?
Etoposide
1
2011
77
0.020
Why?
United States
1
2022
4955
0.020
Why?
Treatment Failure
1
2011
118
0.020
Why?
Fatal Outcome
1
2011
197
0.020
Why?
Drug Administration Schedule
1
2011
370
0.020
Why?
Magnetic Resonance Imaging
1
2017
1548
0.020
Why?
Thanendrarajan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description